Xcout Intel
Surrozen, Inc.
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs’ endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Subscribe to see Surrozen, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Surrozen, Inc. at a glance
Surrozen, Inc. is a biotech company headquartered in South San Francisco, United States. It is publicly listed (SRZN) with a market capitalisation of $148.1M. Xcout tracks 22 named people at Surrozen, Inc., including Craig C. Parker (Chief Executive Officer, President & Director).
Surrozen, Inc. leadership
- Craig C. ParkerChief Executive Officer, President & Director
- Craig ParkerChief Executive Officer
- Charles WilliamsChief Operating Officer & Corporate Secretary
- Andrew MalekiChief Financial Officer
- Calvin KuoCo-Founder & Member of Scientific Advisory Board
- K. Christopher GarciaCo-Founder & Member of Scientific Advisory Board
16 more named people on record for Surrozen, Inc., with roles, board committees and tenure — see the full roster →
Surrozen, Inc. funding rounds on record
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $50M | 4 named |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Surrozen, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Surrozen, Inc. in Xcout Intel
- 22 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access